AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 48 filers reported holding AEROVATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,550 | -54.4% | 19,053 | -42.3% | 0.00% | – |
| Q2 2023 | $566,395 | -37.6% | 33,026 | -26.6% | 0.00% | – |
| Q1 2023 | $907,127 | +1313.7% | 44,974 | +1953.6% | 0.00% | – |
| Q4 2022 | $64,168 | -17.7% | 2,190 | -54.0% | 0.00% | – |
| Q3 2022 | $78,000 | -37.1% | 4,764 | -39.9% | 0.00% | – |
| Q2 2022 | $124,000 | -10.8% | 7,929 | +4.9% | 0.00% | – |
| Q1 2022 | $139,000 | +47.9% | 7,559 | -4.9% | 0.00% | – |
| Q4 2021 | $94,000 | +64.9% | 7,951 | +190.1% | 0.00% | – |
| Q3 2021 | $57,000 | – | 2,741 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |